Immunohistochemistry analysis of VEGF-A 165 b expression in heart

HIF-1 over-expression increases VEGF-dependent proliferation of

Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective - ScienceDirect

VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

Frontiers Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues

Rat VEGF Antibody AF564: R&D Systems

Human VEGF165 Antibody AF-293-NA: R&D Systems

How VEGF-A and its splice variants affect breast cancer development – clinical implications

Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine - ScienceDirect

Differential Apicobasal VEGF Signaling at Vascular Blood-Neural Barriers - ScienceDirect

Anti-VEGF-A Antibody from rabbit, purified by affinity chromatography

VEGF-A splicing: the key to anti-angiogenic therapeutics?

Luisa HUESO, Doctor of Medicine, University of Valencia, Valencia, UV

Temporal changes in levels of serum VEGF-A 165 b in STEMI patients and

A. Representative Graphic of Immunolocalization of VEGFA xxx and VEGFA